コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n) and 375 total events (hard events or late myocardial revascularization).
2 of routine coronary angiography followed by myocardial revascularization).
3 ion or severe unstable angina requiring late myocardial revascularization).
4 on for Cardiothoracic Surgery guidelines for myocardial revascularization.
5 ioplasty are now well established methods of myocardial revascularization.
6 excellent in patients with MCR who underwent myocardial revascularization.
7 ene transfer strategies for the provision of myocardial revascularization.
8 Surgery for myocardial revascularization.
9 asty (PMA) associated with complete surgical myocardial revascularization.
10 l revascularizations; nondiagnostic group, 7 myocardial revascularizations.
13 devices that may revolutionize the field of myocardial revascularization and allow a broader accepta
14 lifestyle changes, optimal medical therapy, myocardial revascularization and the use of antiplatelet
15 d by using the terms atherosclerotic plaque, myocardial revascularization, and plaque stabilization.
16 ospitalization for acute coronary syndromes, myocardial revascularization, arrhythmic event, or strok
17 ndations of the 2018 ESC/EACTS Guidelines on myocardial revascularization as they apply to patients w
18 nvasive strategy (coronary arteriography and myocardial revascularization, as clinically indicated) t
19 ial infarction, sustained kidney injury, and myocardial revascularization) at 1 year were assessed.
20 mprehensive analysis outlines a future where myocardial revascularization becomes increasingly person
25 e of 2989 renal transplant patients required myocardial revascularization either before or after thei
26 cularization modality in patients undergoing myocardial revascularization for LM disease are included
27 ustness of the findings that support current myocardial revascularization guidelines is tenuous and v
28 r of RCTs that support current guidelines on myocardial revascularization have a FI of 3 or lower, an
29 gy (routine coronary angiography followed by myocardial revascularization, if feasible) versus an ear
30 risk for periprocedural complications after myocardial revascularization, in particular neurological
31 larization were measured by the coronary and myocardial revascularization indices (RI(coro) and RI(my
33 MI); positive group, 4 non-Q-wave MIs and 12 myocardial revascularizations; nondiagnostic group, 7 my
34 and late (>3 months after the exercise test) myocardial revascularization, occurred in 41 patients.
35 data could be used to predict the effects of myocardial revascularization on functional status and qu
36 iac surgery has progressed to where surgical myocardial revascularization, or coronary artery bypass
37 tudy retrospectively analyzes the results of myocardial revascularization procedures in these patient
41 ween groups also favored TAVI for additional myocardial revascularization (RR, 0.40; 95% CI, 0.24-0.6
42 failure (RR, 1.8 [CI, 1.3 to 2.6]); previous myocardial revascularization (RR, 1.8 [CI, 1.2 to 2.7]);
44 ic technology has offered the possibility of myocardial revascularization through limited access usin
45 who were provided additional treatments and myocardial revascularization, together with their ratio
46 aluate RCTs supporting current guidelines on myocardial revascularization using the FI and FI minus n
48 ), where the use of coronary angiography and myocardial revascularization was guided by the developme